Legal advisor to MC Groep on the acquisition of Slotervaart Hospital

Acted as legal advisor to MC Groep in connection with the acquisition of a majority interest in Slotervaart Hospital.

MC Groep, a private healthcare group led by former physician Loek Winter, acquired the interest from the heirs of businessman John Schram. The transaction followed a complex shareholder dispute involving the minority shareholder, the heirs and other stakeholders. The existing case page states that the transaction value was understood at the time to be between EUR 25 million and EUR 35 million and that ING and Achmea had extended support for the transaction.

The legal work related to the transaction, the shareholder context and the implementation of the acquisition. Healthcare transactions require careful attention to governance, continuity of care, stakeholder interests, financing conditions, contractual obligations and regulatory considerations.

This transaction illustrates that M&A in the healthcare sector is not only about price and transaction documentation, but also about governance, public sensitivity and execution in a complex operational environment.

Need legal advice on a Dutch M&A transaction?

For questions about acquisitions, sale processes, shareholder structures or transaction documentation in the Netherlands, please contact dirk.dewaard@viottalaw.com.

Deal highlights

Transaction type – Acquisition / healthcare M&A

Client – MC Groep

Target – Slotervaart Hospital

Sector – Healthcare / hospitals

Role – Legal advisor to MC Groep

Transaction value – between EUR 25 million and EUR 35 million.

Legal work – Transaction documentation, shareholder context, governance and implementation support

External links

Dealmaker.nl — MC Groep acquires Slotervaart Hospital

Related expertise

Corporate / M&A
Share purchase agreements
Corporate Governance
Commercial contracts

Involved lawyers.

If you need a legal opinion under Dutch law, please do not hesitate to contact us via
info@viottalaw.com or +31 20 248 06 00.

By VIOTTA.

Recent cases.

By VIOTTA.

More articles.

16 / 10 2026

Lessons from Cross-Border Transactions: Dutch Deal Execution in Practice

Practical observations from cross-border transactions involving Dutch companies, focusing on transaction management, drafting, due diligence, closing mechanics and Dutch implementation.

READ ARTICLE
16 / 10 2026

Preparing a Dutch Company for Investment or Sale

A practical Dutch deal-readiness guide covering ownership, governance, contracts, IP, management incentives, corporate approvals and data-room preparation before an investment or sale.

READ ARTICLE
15 / 10 2026

VC Term Sheets in Dutch Financing Rounds: What Is Binding and What Is Not?

A practical insight for international investors and counsel on Dutch VC term sheets: which commercial terms remain non-binding, which process provisions should bind immediately and how the term sheet moves into Dutch BV financing documentation.

READ ARTICLE
08 / 10 2026

Can a Dutch NV Remain TopCo for a Nasdaq Listing? The InoBat Structure

The proposed InoBat transaction shows how a Dutch N.V. can serve as TopCo in a Nasdaq structure involving preference shares, warrants, employee options and PIPE financing.

READ ARTICLE
08 / 10 2026

Digital Shareholder Meetings in Dutch Companies from 2027

From 1 January 2027, Dutch companies can use fully digital shareholder meetings if the articles and meeting process meet the statutory requirements. The change is relevant for international shareholder governance and transaction approvals.

READ ARTICLE
08 / 10 2026

Share Options for Dutch Employees Under a Foreign Parent Company Plan

Foreign parent companies can grant options to employees of a Dutch subsidiary. This insight explains the Dutch implementation layer: local documentation, grant administration, employee mobility and the treatment of Dutch participants in a group exit.

READ ARTICLE